We are establishing partnerships and high quality research programmes focusing on areas of unmet need which benefit the poorest and most vulnerable populations in Low and Middle Income Countries (LMICs).

We are working with established UK and global funders of health to support existing, high-quality partnership schemes and co-create new ones in research areas where there is an established and/or unmet need. Working together with funding bodies that have a strong track-record in global health research, we are assuring added value on our funding investment. These high-quality programmes align with DHSC strategic research areas, and are for the primary benefit of the poorest and most vulnerable populations in LMICs. Please see our funding opportunities page for open calls. 

Funded partnerships include:  


Call title and link

NIHR contribution



 Research to improve adolescent health in LMIC settings


Closed September 2018

MRC*, DFIDWellcome

 Joint Global Health Trials - call 9


Closed September 2018


 Global Alliance for Chronic Disease (GACD)


Closed September 2018


Health in Humanitarian Crises (R2HC)


Closed July 2018

MRC*, DFIDWellcome

Joint Global Health Trials Initiative

£35m over 5 years

Annual call


AMR cross-council Initiative: Antimicrobial Resistance in a Global Context


Closed July 2017


Research to Improve Adolescent Health in LMIC Settings  - call 2


Closed June 2017


Diagnostics, Prosthetics and Orthotics to Tackle Health Challenges in Developing Countries


Closed May 2017


Research and clinical management of patients in poverty-related disease epidemics in sub-Saharan Africa


Closed March 2017


Clinical Trials and operational research studies to optimise the use of products for poverty-related diseases in mothers, new-borns, children and adolescents


Closed March 2017



AMR cross-council initiative: Behaviour within and beyond the healthcare setting


Closed 2016


Antimicrobial Resistance Structured Operational Research and Training Initiative (AMR SORT IT)


Opening January 2019


Global Maternal and Neonatal Health


Opening 16 January 2019

*lead partner


Product Development Partnerships (PDPs)

PDPs address the gap between the unmet need for new treatments and other interventions for diseases of poverty in the developing world, and the resources available to develop them. The PDPs bring together partners from academia, industry, the public sector and multilateral agencies to develop effective, affordable, appropriate and accessible products. PDPs have also stimulated increased collaboration of the pharmaceutical industry to work on the diseases of poverty (DoP).

With due consideration of the global need, and in consultation with DfID, the NIHR has made contributions to the following PDPs:

Medicines for Malaria Venture (MMV)


TB Alliance


Foundation for Innovative New Diagnostics (FIND)



The NIHR also plays a role in administering ODA funding for the Department of Health and Social Care’s strategic area of Global Health Security. The NIHR ran one competition and administer a second one aimed at developing vaccine candidates, and related technologies and processes, to combat 12 pathogens capable of causing epidemics in LMICs, as identified by the UK Vaccine Network. These competitions were:

  • Research Call for Vaccine development from research groups at MRC/BBSRC Intramural centres. Using £12m ODA funding, proposals were invited for the development of vaccine candidates against the 12 priority pathogens. Successful projects are administered by NIHR.
  • Research Call on Epidemiology for Vaccinology. Using £5m ODA funding, we invited proposals on the use and development of epidemiological models, tools and technologies to assist with the deployment and clinical trialling of vaccines in outbreak situations in LMICs (Closed 2017).

These two competitions are part of a wider programme of work being funded by DHSC. You can find more information about this programme and the UK Vaccine Network here.